Financial reports
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
10 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Departure of Directors or Certain Officers
6 Mar 24
8-K
Departure of Directors or Certain Officers
20 Feb 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
Changes in Registrant's Certifying Accountant
3 Jan 24
8-K
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
7 Dec 23
8-K
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
2 Oct 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
8-K
Regulation FD Disclosure
24 Jul 23
8-K
Entry into a Material Definitive Agreement
21 Jul 23
Registration and prospectus
S-1
IPO registration
31 Oct 23
D
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
3 Oct 23
424B5
Prospectus supplement for primary offering
2 Oct 23
424B5
Prospectus supplement for primary offering
21 Jul 23
S-8
Registration of securities for employees
14 Jul 23
D
$20.00 mm in equity, sold $20.00 mm, 8 investors
15 Nov 22
S-3/A
Shelf registration (amended)
19 Nov 21
S-3
Shelf registration
2 Apr 21
424B5
Prospectus supplement for primary offering
16 Feb 21
424B5
Prospectus supplement for primary offering
16 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
21 Nov 22
PRE 14A
Preliminary proxy
9 Nov 22
DEFA14A
Additional proxy soliciting materials
26 Jul 22
DEFA14A
Additional proxy soliciting materials
22 Jul 22
DEFA14A
Additional proxy soliciting materials
29 Jun 22
DEFA14A
Additional proxy soliciting materials
24 Jun 22
DEFA14A
Additional proxy soliciting materials
14 Jun 22
DEFA14A
Additional proxy soliciting materials
31 May 22
Other
EFFECT
Notice of effectiveness
9 Nov 23
CORRESP
Correspondence with SEC
6 Nov 23
UPLOAD
Letter from SEC
3 Nov 23
EFFECT
Notice of effectiveness
26 Nov 21
CORRESP
Correspondence with SEC
22 Nov 21
UPLOAD
Letter from SEC
7 Apr 21
EFFECT
Notice of effectiveness
25 Nov 20
CORRESP
Correspondence with SEC
20 Nov 20
CORRESP
Correspondence with SEC
20 Nov 20
UPLOAD
Letter from SEC
5 Nov 20
Ownership